Millennium Management’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$31.4M Sell
3,852,545
-617,538
-14% -$5.6M 0.01% 1194
2025
Q4
$30M Buy
4,470,083
+2,342,804
+110% +$17.7M 0.01% 1188
2025
Q3
$18.4M Buy
2,127,279
+105,060
+5% +$818K 0.01% 1752
2025
Q2
$12.7M Buy
2,022,219
+1,160,814
+135% +$7.69M 0.01% 2012
2025
Q1
$5.52M Sell
861,405
-140,028
-14% -$1.16M ﹤0.01% 2757
2024
Q4
$8.05M Sell
1,001,433
-791,408
-44% -$7.63M ﹤0.01% 2383
2024
Q3
$22.6M Buy
1,792,841
+1,538,063
+604% +$19.9M 0.01% 1439
2024
Q2
$3.23M Buy
254,778
+228,550
+871% +$2.3M ﹤0.01% 3124
2024
Q1
$125K Sell
26,228
-394,198
-94% -$1.83M ﹤0.01% 5522
2023
Q4
$2.02M Sell
420,426
-2,136,070
-84% -$13.1M ﹤0.01% 3599
2023
Q3
$18.5M Buy
2,556,496
+2,494,230
+4,006% +$19.9M 0.01% 1497
2023
Q2
$463K Buy
62,266
+12,009
+24% +$94.4K ﹤0.01% 4599
2023
Q1
$348K Sell
50,257
-1,500,405
-97% -$13.8M ﹤0.01% 4815
2022
Q4
$15.9M Buy
1,550,662
+1,023,328
+194% +$18.1M 0.01% 1651
2022
Q3
$9.6M Sell
527,334
-342,076
-39% -$14.8M 0.01% 2199
2022
Q2
$44.7M Buy
869,410
+253,477
+41% +$13.1M 0.03% 722
2022
Q1
$45.4M Buy
615,933
+609,312
+9,203% +$54.3M 0.02% 754
2021
Q4
$947K Sell
6,621
-183,328
-97% -$31.5M ﹤0.01% 4455
2021
Q3
$39.4M Sell
189,949
-134,573
-41% -$29.7M 0.02% 776
2021
Q2
$68.9M Sell
324,522
-39,244
-11% -$7.19M 0.04% 460
2021
Q1
$66M Buy
363,766
+183,245
+102% +$36.5M 0.05% 381
2020
Q4
$20.1M Sell
180,521
-128,760
-42% -$13.7M 0.01% 1064
2020
Q3
$33.5K Buy
309,281
+151,213
+96% +$18.4M 0.04% 503
2020
Q2
$13.2M Sell
158,068
-472,646
-75% -$18.1M 0.02% 1020
2020
Q1
$8.56M Buy
630,714
+609,860
+2,924% +$5.16M 0.02% 962
2019
Q4
$83K Buy
20,854
+6,932
+50% +$30.1K ﹤0.01% 4048
2019
Q3
$69K Buy
13,922
+1,451
+12% +$7.94K ﹤0.01% 4009
2019
Q2
$73K Sell
12,471
-12,068
-49% -$95K ﹤0.01% 3929
2019
Q1
$270K Sell
24,539
-122,175
-83% -$3.86M ﹤0.01% 3602
2018
Q4
$5.4M Buy
146,714
+82,297
+128% +$3.19M 0.01% 1535
2018
Q3
$2.42M Sell
64,417
-20,190
-24% -$569K ﹤0.01% 2310
2018
Q2
$2.27M Sell
84,607
-181,359
-68% -$6.13M ﹤0.01% 2309
2018
Q1
$11.2M Buy
265,966
+205,368
+339% +$8.25M 0.01% 1268
2017
Q4
$1.5M Sell
60,598
-158,612
-72% -$3.87M ﹤0.01% 2450
2017
Q3
$5M Buy
219,210
+199,330
+1,003% +$4.46M 0.01% 1675
2017
Q2
$457K Sell
19,880
-195,400
-91% -$3.83M ﹤0.01% 2847
2017
Q1
$5.51M Buy
215,280
+58,526
+37% +$1.61M 0.01% 1400
2016
Q4
$3.95M Sell
156,754
-119,661
-43% -$3.49M 0.01% 1483
2016
Q3
$11.5M Buy
276,415
+274,660
+15,650% +$35.5M 0.02% 861
2016
Q2
$255K Sell
1,755
-51,020
-97% -$5.85M ﹤0.01% 2804
2016
Q1
$5.45M Buy
+52,775
New +$5.66M 0.01% 1204
2015
Q4
Sell
-99,531
Closed -$14.1M 3671
2015
Q3
$14.1M Buy
99,531
+70,556
+244% +$15.8M 0.03% 743
2015
Q2
$6.46M Buy
28,975
+13,628
+89% +$2.4M 0.01% 1225
2015
Q1
$2.54M Sell
15,347
-31,890
-68% -$5.18M ﹤0.01% 1800
2014
Q4
$5.6M Buy
47,237
+39,965
+550% +$4.18M 0.01% 1318
2014
Q3
$607K Buy
+7,272
New +$657K ﹤0.01% 2638
2014
Q2
Sell
-30,570
Closed -$2.77M 3728
2014
Q1
$2.77M Buy
30,570
+8,257
+37% +$922K 0.01% 1551
2013
Q4
$2.29M Sell
22,313
-8,696
-28% -$614K 0.01% 1732
2013
Q3
$1.95M Buy
+31,009
New +$1.75M 0.01% 1699

Other funds holding NVAX

Millennium Management's NVAX Position: Q1 2026 in Review

Millennium Management reduced its Novavax (NVAX) stake by 14% in Q1 2026, selling an estimated $5.6M and leaving 3,852,545 shares worth $31.4M. The position accounts for 0.01% of the portfolio, ranked #1194.

Millennium Management first reported a position in NVAX in Q3 2013 and has held it in 49 quarters since. The position peaked at $68.9M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.

  • Millennium Management held 3,852,545 shares of Novavax worth $31.4M as of Q1 2026.
  • Millennium Management sold 617,538 Novavax shares in Q1 2026, an estimated $5.6M.
  • Novavax made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1194 holding.
  • Millennium Management first reported a position in Novavax in Q3 2013 and has held it in 49 quarters since.
  • Millennium Management's Novavax position peaked at $68.9M in Q2 2021.
  • 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.